Cardiac muscle depolarization

Cardiac muscle depolarization refers to a physiological event, not a single molecule, protein, or classical pharmacological target. It is the process by which a cardiac myocyte's membrane potential rapidly shifts from a negative resting state (about -90 mV) to a positive value, primarily due to the influx of sodium ions through voltage-gated sodium channels during phase 0 of the cardiac action potential. This event triggers a cascade involving opening of calcium channels (notably L-type calcium channels), which sustains the plateau phase and is essential for excitation-contraction coupling that leads to muscle contraction. Special pacemaker cells (e.g., in the sinoatrial node) display distinct spontaneous depolarization because of mixed Na(^+)/Ca(^{2+}) currents, setting the heart's rhythm, while contractile cardiomyocytes depolarize only when stimulated, ensuring coordinated contraction and efficient blood pumping[3][5][9]. Cardiac muscle depolarization, as a concept, thus encompasses the action of many molecular targets (especially specific sodium, calcium, and potassium ion channels), and disruptions in ion channel function can underlie arrhythmias and other cardiac pathologies[2][4][8]. However, "cardiac muscle depolarization" is not itself a unique molecular entity or drug target, hence any structured drug discovery or biomarker information must focus on the specific ion channels or proteins involved and not the overall process.